Bladder and upper tract urothelial cancer.

Bladder and upper tract urothelial cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Bladder and upper tract urothelial cancer. Abstract Text:

Badrinath R Konety,Geoffrey F Joyce,Matthew Wise,

PURPOSE: While there are data available indicating the incidence and prevalence of bladder and upper tract urothelial cancer, population level data on resource use, costs and patterns of care for these cancers are limited. We quantified the economic impact of caring for patients with bladder and upper tract urothelial cancer, and determined the primary drivers for such costs in the population in the United States. MATERIALS AND METHODS: The analytical methods used to generate these results have been described previously. RESULTS: An increasing proportion of patients with bladder and upper tract urothelial cancer were being treated in the outpatient setting. Most care was provided by urologists and visit frequency was directly related to disease stage. Only a small proportion of patients potentially eligible for chemotherapy, ie those with advanced disease, sought specialized care from oncologists. Office based diagnostic tests such as cytology were not commonly done, although a substantial number of patients with bladder cancer underwent cystoscopy. The use of excretory urography in these patients was decreasing, while the use of computerized tomography was increasing. Ileal conduits were the most frequently performed type of urinary diversion following cystectomy. The cystectomy rate remained unchanged for a decade. Intravesical therapy was done infrequently in patients with bladder cancer. Annual costs for treating bladder and upper urinary tract cancers were $1 billion and $64 million, respectively, in 2000. These costs represented a $164 million increase over 1994 levels, which outpaced inflation. CONCLUSIONS: The costs of treating bladder cancer increased steadily during a 6-year period despite a decrease in inpatient care. Coupled with a lack of substantial change in transurethral resection and cystectomy rates, this suggests that the primary cost drivers are increased outpatient testing, eg computerized tomography and cystoscopy, and an increase in the number of diagnosed cases. Greater focus on selective use of testing modalities, preventive care such as smoking cessation and earlier identification of patients at risk may help curtail further expenditure with regard to managing bladder and upper urinary tract cancers.

Bladder and upper tract urothelial cancer. Publishing Authors By Initials

BR Konety,GF Joyce,M Wise,

For similar tissues: epithelium: urothelium research abstracts see: tissues: epithelium: urothelium research

PUBMED ID PMID:

MEDLINE DATE:

Bladder and upper tract urothelial cancer. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: The Journal of urology

VOLUME: 177

Page Numbers: 1636-45

Journal Abbreviation:

ISSN: 0022-5347

DAY: 3

MONTH: May

YEAR: 2007

Bladder and upper tract urothelial cancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 376374

Bladder and upper tract urothelial cancer. Keywords Mesh Terms:

KEYWORDS: Urothelium

MESH TERMS: pathology

Chemical & Substance for Abstract: Bladder and upper tract urothelial cancer. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Bladder and upper tract urothelial cancer.

AFFILIATION: Department of Urology, University of California-San Francisco, San Francisco, CA 94143-1695, USA. bkonety@urology.ucsf.edu

Country: United States

AGENCY: United States NIDDK

GRANT: N01-DK-1-2460

ACRONYM: DK

MEDLINETA: J Urol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Bladder and upper tract urothelial cancer Related Publications

• A low-profile three-dimensional silicon/parylene stimulating electrode array for neural prosthesis applications.
• All-normal-dispersion femtosecond fiber laser with pulse energy above 20 nJ.
• Atomoxetine pharmacokinetics in healthy Chinese subjects and effect of the CYP2D6*10 allele.
• Benzo[a]pyrene cytotoxicity in right whale (Eubalaena glacialis) skin, testis and lung cell lines.
• Bladder and upper tract urothelial cancer.
• Chronic exposure to particulate chromate induces spindle assembly checkpoint bypass in human lung cells.
• Chronological gene expression of parathyroid hormone-related protein (PTHrP) in the stellate reticulum of the rat: implications for tooth eruption.
• Combined Training and beta-Alanine Supplementation Muscle Carnosine Synthesis, Ventilatory Threshold and Exercise Capacity in Cyclists: 2069: Board #139 May 31 3:30 PM 5:00 PM.
• Commentary: "will medical solutions to sexual problems make sexological care and science obsolete?".
• Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men.
• Determination of HBCD, PBDEs and MeO-BDEs in California sea lions (Zalophus californianus) stranded between 1993 and 2003.
• Effect of vascular endothelial growth factor on RANK gene expression in osteoclast precursors and on osteoclastogenesis.
• Efficient high-energy femtosecond pulse compression in quadratic media with flattop beams.
• Estradiol targets synaptic proteins to induce glutamatergic synapse formation in cultured hippocampal neurons: critical role of estrogen receptor-alpha.
• Feasibility of retinoids for the treatment of emphysema study.
• Four week supplementation with mixed fruit and vegetable juice concentrates increased protective serum antioxidants and folate and decreased plasma homocysteine in Japanese subjects.
• Kidney cancer.
• Ku80 deficiency does not affect particulate chromate-induced chromosome damage and cytotoxicity in Chinese hamster ovary cells.
• Male urethral stricture disease.
• Neural correlates of intelligibility in speech investigated with noise vocoded speech--a positron emission tomography study.
• Nonlocal explanation of stationary and nonstationary regimes in cascaded soliton pulse compression.
• Particulate and soluble hexavalent chromium are cytotoxic and genotoxic to human lung epithelial cells.
• Role of the Fancg gene in protecting cells from particulate chromate-induced chromosome instability.
• Scaling of femtosecond Yb-doped fiber amplifiers to tens of microjoule pulse energy via nonlinear chirped pulse amplification.
• Sex differences in severe pulmonary emphysema.
• Standard reference materials for foods and dietary supplements.
• The clastogenic effects of chronic exposure to particulate and soluble Cr(VI) in human lung cells.
• The continuing conundrum of the LEA proteins.
• The shift from defined benefit pensions to 401(k) plans and the pension assets of the baby boom cohort.
• XRCC1 protects cells from chromate-induced chromosome damage, but does not affect cytotoxicity.